# National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study

> **NCT01123265** · — · COMPLETED · sponsor: **University of Rochester** · enrollment: 22 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Anti-TNF

## Key facts

- **NCT ID:** NCT01123265
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2015-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01123265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01123265, "National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01123265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*